Scenarios that move REGN
Regeneron Pharmaceuticals, Inc. - Common Stock
Scenarios that move REGN: 11 analyses, 3 positive, 8 negative.
- · Roche reports positive Phase III eye drug data, FDA accepts BLA — ▼ · impact -75 · confidence high · horizon quarters
- · HALO wins court order blocking Merck's European Keytruda SC — ▲ · impact +15 · confidence low · horizon quarters
- · Genmab and AbbVie report positive epcoritamab lymphoma trial results — ▼ · impact -45 · confidence low · horizon quarters
- · Liquidia stock plunges 57% after UTHR patent setback — ▼ · impact -20 · confidence low · horizon weeks
- · DBV Technologies files FDA BLA for VIASKIN Peanut patch — ▼ · impact -10 · confidence medium · horizon quarters
- · Mirum's Brelovitug meets goal in Phase III AZURE-1 study — ▲ · impact +18 · confidence low · horizon quarters
- · Kodiak Sciences shares soar 178% on positive wet AMD data — ▼ · impact -58 · confidence high · horizon quarters
- · Zymeworks updates 2026 guidance after Theravance acquisition — ▼ · impact -40 · confidence low · horizon quarters
- · ADARx Pharmaceuticals prices upsized $446.3 million initial public offering — ▼ · impact -19 · confidence medium · horizon quarters
- · Ionis reports positive late-stage results for two partnered drugs — ▼ · impact -30 · confidence low · horizon quarters
- · Amgen shares fall after Novartis' Pelacarsen misses Phase III goal — ▲ · impact +30 · confidence medium · horizon quarters